Contract Research Annual Review 2009

Publication Date	June 2009
Publisher	Biopharm Knowledge
Product Type	Report
Pages
ISBN Number	not applicable
Product Code	BKP00013

Buy this product or for assistance call +44 20 7060 7474

PDF £345.00$574 | €386

FAX Order above formats by FAX

Summary

The Complete Picture of the Contract Research Market

The contract research market grew by 12% last year and performed far better than the pharma market that it serves - but this year growth has stopped and the market cap of publicly quoted CROs has fallen sharply. Why has growth stopped, and why have share prices fallen in a market that was booming? This review provides a complete picture of the market, looks at trends and developments and explains why they have happened and how they will affect the future of the market. And it includes a unique, detailed explanation of the value proposition of outsourcing pharmaceutical development.

With 31 graphs and 16 tables, this 200-page review includes:

Market size
Market growth
Analysis of the CRO market by:
Type of company
Service offering
Therapy class
Market trends including:
M and A activity
CROs in developing regions
Details of more than 50 mergers, acquisitions and joint ventures.
An 150-page news section covering leading CROs.

Content

Introduction
The CRO Market 2008/9
How can CROs increase the value of projects - a financial analysis
- Introduction
- A Definition of Value
- The Development Scenario
- Calculations of Net Present Value
- Conclusions & Recommendations
Analysis of CROs by Type of Company
Analysis of the Size of the CRO Market
CRO Mergers, Acquisitions & Joint Ventures 2008/9
Analysis by Size of CRO
Distribution of CROs by Service Offering
Analysis by Clinical Services Offered
Analysis by Therapeutic Area
CROs in Developing Countries
Analysis of CROs by Size - Numbers of Employees
Summary and Conclusions
News of the CROs 2008/9
List of Tables & Graphs within Annual Review
- Table 1: Distribution of CROs by Company Type
- Table 2: Leading CROs
- Table 3: Stock Market Performance of CROs
- Table 4: CRO Mergers, Acquisitions & Joint Ventures
- Table 5: Absolute Growth Figure for CROs
- Table 6: Peak Years of CRO Growth
- Table 7: Peak Years of Rates of Formation
- Table 8: Number of Beds in CROs by Region
- Table 9: Principal Areas of Therapeutic Experience - Europe
- Table 10: Principal Areas of Therapeutic Experience - North America
- Table 11: CEE CROs
- Table 12: South American CROs
- Table 13: Asian CROs
- Table 14: Staff in CROs in Europe
- Table 15: Staff in CROs in North America
- Table 16: Clinical Staff in CROs
- Figure 1: Types of Company (European) Clinical
- Figure 2: Types of Company (European) Preclinical
- Figure 3: Types of Company (North American) Clinical
- Figure 4: Types of Company (North American) Preclinical
- Figure 5: Annual Revenues of Public CROs
- Figure 6: Total Annual Revenues of Leading CROs
- Figure 7: Market Capitalisation of Leading CROs
- Figure 8: Annual Revenues of European CROs
- Figure 9: Annual Revenues of North American CROs
- Figure 10: Growth of the Overall Market
- Figure 11: 3-Year Average Rate of Formation European Clinical CROs
- Figure 12: 3-Year Average Rate of Formation European Preclinical CROs
- Figure 13: 3-Year Average Rate of Formation North American Clinical CROs
- Figure 14: 3-Year Average Rate of Formation North American Preclinical CROs
- Figure 15: CRO Services Offered Directly (Europe)
- Figure 16: CRO Services Offered Directly (North America)
- Figure 17: Clinical CROs by Country
- Figure 18: Data Management / Statistics CROs by Country
- Figure 19: Regulatory CROs by Country
- Figure 20: Preclinical / Toxicology CROs by Country
- Figure 21: Analytical CROs by Country
- Figure 22: cGMP Labs by Country
- Figure 23: Clinical Chemistry (Central Labs) by Country
- Figure 24: Evolution of CROs Performing Phase II-IV Studies in Europe
- Figure 25: Evolution of CROs Performing Phase II-IV Studies in North America
- Figure 26: Evolution of CROs Performing Volunteer Studies in Europe
- Figure 27: Evolution of CROs Performing Volunteer Studies in North America
- Figure 28: Areas of Therapeutic Experience of European CROs
- Figure 29: Other Areas of Experience of European CROs
- Figure 30: Areas of Therapeutic Experience of North American CROs
- Figure 31: Other Areas of Experience of North American CROs